Navigation Links
Well-known author and historian reports on progress in Huntington's therapies
Date:6/25/2012

Amsterdam, NL, June 25, 2012 Our understanding of the causes and mechanisms of Huntington's disease (HD) has grown at a dramatic pace since the discovery of the genetic marker for the disease in 1983. While therapies to treat the disease lag behind these laboratory discoveries, disease altering interventions are moving closer to the clinic. In the inaugural issue of the Journal of Huntington's Disease Alice Wexler, PhD, an authority on the history of Huntington's disease, author, and research scholar with the UCLA Center for the Study of Women, recounts important milestones along the journey towards a treatment or cure for the disease.

"When the abnormal gene that causes HD was identified in 1993, many of us in HD families imagined that a cure or at least an effective treatment was close at hand," says Dr. Wexler. "That dream has not yet been realized. But if the history of HD can provide clues for the future, it suggests that change doesn't always happen gradually. It can also happen swiftly. And that, I believe, is a great source for hope."

Although clinical accounts of HD date back to the mid-19th century, as late as the 1960s few doctors knew anything about it. Those who did could offer no effective treatments and families with the illness tried hard to keep it hidden. "All of a sudden, in the 1960s, this began to change," says Dr. Wexler. Grassroots advocacy by HD families, and the efforts of a small international network of neurologists who formed international collaborations to study the disease, began to have an impact.

The genetic marker for HD was discovered in 1983, and HD research intensified. It reached a dramatic turning point in 1993, when the discovery of the genetic abnormality that causes HD made possible an array of new models and experimental approaches. Since then, scientists have created a variety of new animal and cell models, identified potential genetic modifiers, and illuminated many aspects of neuronal dysfunction. They are also testing methods of gene silencing and other novel therapeutic strategies in a variety of animal models.

"For families struggling daily with HD, effective intervention can't come soon enough," says Dr. Wexler. "But the volume of research has increased tremendously in the past decade. Disease altering interventions are moving closer to the clinic. The launch of the Journal of Huntington's Disease provides a welcome new resource in our campaign to heal a formidable disease."


'/>"/>

Contact: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Related medicine news :

1. Preventing Oral Diseases Begins in Pregnancy Claims Author in New eBook
2. Dr. Carol Francis Radio Talk Show Discusses Sexual Abuse as Related to "Coach" Jerry Sandusky; Interview With Abuse Survivor Teresa Joyce, Author of "There's A Fine Line"
3. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
4. Reactions to HIV drug have autoimmune cause, reports AIDS journal
5. Study examines necessity of additional imaging in PET/CT oncologic reports
6. 1 in 3 households misreports smoke alarm coverage
7. Mount Sinai researcher finds timing of ADHD medication affect academic progress
8. San Diego Physician to be Recognized at White House for Progress in Health IT
9. No Progress in Reducing U.S. Motorcycle Deaths: Report
10. Biosynthetic grape-derived compound prevents progression of Alzheimers disease in mice
11. RANK protein promotes the initiation, progression and metastasis of human breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: